Cell Investigation

KeAi Communications Co., Ltd.

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Cell Investigation is an open-access journal published by KeAi Communications Co., Ltd. in China, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,500 USD. Declared review time at DOAJ: 9 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
KeAi Communications Co., Ltd.
ISSN
3050-5380
Country
China
Languages
english
Access
Open access
Declared publication charge
2,500 USD
Articles in DOAJ
49
Declared review time
9 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2026-04-17
Indexing
DOAJ
APC
2,500 USD
Declared review time (DOAJ)
9 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

49

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

9weeks

Works in OpenAlex

46

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

9

i10-index

7

From OpenAlex open data (CC0).

Editorial & policy9
Added to DOAJ
2026-04-17
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
92%
ORCID iDs in current deposits
58%
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Cell investigation
Source type
journal
NLM unique ID (PubMed)
9918991784006676
Classification2

Subjects (DOAJ)

Science: Biology (General): Genetics

LCC codes

QH426-470

Subject areas

  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Cancer Immunotherapy and Biomarkers
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Ferroptosis and cancer prognosis
  • interferon and immune responses
  • RNA regulation and disease
Show all subjects (75)
  • RNA modifications and cancer
  • RNA Research and Splicing
  • interferon and immune responses
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Acute Myeloid Leukemia Research
  • RNA Research and Splicing
  • Blood disorders and treatments
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Cancer-related Molecular Pathways
  • Acute Myeloid Leukemia Research
  • Cancer-related molecular mechanisms research
  • Circular RNAs in diseases
  • Circular RNAs in diseases
  • MicroRNA in disease regulation
  • interferon and immune responses
  • RNA Research and Splicing
  • Cancer, Hypoxia, and Metabolism
  • Cancer Genomics and Diagnostics
  • Cancer, Hypoxia, and Metabolism
  • Protein Kinase Regulation and GTPase Signaling
  • Glioma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • MicroRNA in disease regulation
  • Epigenetics and DNA Methylation
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Bladder and Urothelial Cancer Treatments
  • Renal cell carcinoma treatment
  • DNA Repair Mechanisms
  • Genomics and Chromatin Dynamics
  • Epigenetics and DNA Methylation
  • CRISPR and Genetic Engineering
  • Ubiquitin and proteasome pathways
  • Peroxisome Proliferator-Activated Receptors
  • Nanoplatforms for cancer theranostics
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Reproductive Biology and Fertility
  • Chronic Lymphocytic Leukemia Research
  • Ferroptosis and cancer prognosis
  • Acute Myeloid Leukemia Research
  • Brain Metastases and Treatment
  • Cancer Cells and Metastasis
  • Peroxisome Proliferator-Activated Receptors
  • Ubiquitin and proteasome pathways
  • CRISPR and Genetic Engineering
  • Epigenetics and DNA Methylation
  • Genomics and Chromatin Dynamics
  • DNA Repair Mechanisms
  • Cell death mechanisms and regulation
  • Genomics and Chromatin Dynamics
  • DNA Repair Mechanisms
  • Nanoplatforms for cancer theranostics
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Reproductive Biology and Fertility
  • Reproductive Biology and Fertility
  • Cancer Cells and Metastasis
  • Thyroid Cancer Diagnosis and Treatment
  • Sperm and Testicular Function
  • Ferroptosis and cancer prognosis
  • Prostate Cancer Treatment and Research

Keywords (DOAJ)

  • senescence
  • cancer biology
  • rna biology
  • molecular biology of health and disease
  • molecular genetics and epigenetic regulation
  • tumor microenvironment and cancer immunotherapy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: